A landmark human trial testing a vaccine that’s designed to help the immune system target brain tumors has shown promising results—and Phase 2 of the trial is now being planned. According to a Nature article published by the researchers leading the trial, the vaccine was safe for all patients, and showed the hoped-for immune response […]

The post New Brain Cancer Immunotherapy Shows Promise in Human Trial – Most Patients Saw No Tumor Growth For 3 Years appeared first on Good News Network.